DexCom is expected to report increased earnings, with analysts optimistic despite recent dips.

DexCom, Inc. is set to release its fiscal 2025 second-quarter earnings on July 30. Analysts predict a profit of $0.45 per share, a 4.7% increase from the previous year. For the full year, EPS is expected to be $2.03, a 23.8% rise from fiscal 2024. Despite a 25.2% drop in shares over the past 52 weeks, analysts remain optimistic, giving DXCM a “Strong Buy” rating. With an average price target of $99.68, there is a projected 20.2% potential upside. Changes in government payment schedules caused a brief 4% dip in shares on July 1, impacting the glucose monitoring and insulin pump sector.

Read more at Yahoo Finance: What You Need to Know Ahead of DexCom’s Earnings Release